CUMBERLAND PHARMACEUTICALS (CPIX)

US2307701092 - Common Stock

1.76  +0.06 (+3.53%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
39.55M42.01M35.99M37.44M34.39M
Minority Interest Expense
51.45K79.80K95.21K80.00K10.00K
Cost Of Goods
6.07M8.62M7.41M8.45M7.42M
Gross Profit
33.49M33.39M28.57M28.99M26.97M
Operating Expenses
39.70M38.60M34.85M35.17M36.26M
Research and Development
5.83M6.69M5.68M5.77M6.87M
Selling, General, and Administrative Expenses
28.93M26.58M24.56M24.96M25.25M
Operating Income
-6.21M-5.20M-6.28M-6.18M-9.29M
Interest Income/Expense
-381.01K-487.59K-71.95K-190.00K0.00
Other Income/Expense
3.65M611.33K2.19MN/AN/A
Non Recurring Items
-3.34M-500.00K-1.40M-200.00K0.00
Income Before Taxes
-6.29M-5.58M-5.56M-6.57M-9.29M
Income Tax
45.77K68.85K34.89K60.00K-80.00K
Net Income
-6.28M-5.57M-3.51M-3.34M-3.54M
EBITDA
-1.27M123.18K-1.67M-1.43M-4.89M
 
Per Share Data
EPS Diluted Total Ops
-0.44-0.38-0.23-0.22-0.22
Non GAAP EPS
0.18N/AN/A0.120.31
 
Statistics
Gross Profit Margin
84.66%79.49%79.40%77.43%78.42%
Profit Margin
-15.88%-13.26%-9.75%-8.92%-10.29%
Operating Profit Margin
-15.70%-12.39%-17.44%-16.51%-27.01%

All data in USD

Charts